Answer
Parsabiv (etelcalcetide hydrochloride) should preferably be avoided during pregnancy as a precaution because human pregnancy data are absent or limited, although animal studies indicate no direct or indirect reproductive harm.
Sources for this answer
- ParsabivAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked